Radiopharmaceuticals for diagnosing alzheimer's disease

Details for Australian Patent Application No. 2002214034 (hide)

Owner Schering AG

Inventors Mading, Peter; Hesselgesser, Joseph E.; Johannsen, Bernd; Dinter, Harald; Hilger, Christoph-Stephan; Halks-Miller, Meredith; Steinbach, Jorg; Horuk, Richard; Mohan, Raju

Agent Davies Collison Cave

Pub. Number AU-B-2002214034

PCT Pub. Number WO02/36581

Priority 60246299 06.11.00 US

Filing date 1 November 2001

Wipo publication date 15 May 2002

Acceptance publication date 5 January 2006

International Classifications

C07D 295/18 (2006.01) Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

C07B 59/00 (2006.01) Introduction of isotopes of elements into organic compounds

Event Publications

5 January 2006 Application Accepted

  Published as AU-B-2002214034

4 May 2006 Standard Patent Sealed

24 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002214035-Substituted alkyldiamines as inhibitors of plasmepsin or related proteases

2002214033